GetPortalImpactFactorByIdResp(projectId=1, id=6c7f21089, cover=https://img.medsci.cn/202201022/1666460870767_4754896.png, fullname=Case Reports in Oncology, abbr=CASE REP ONCOL, pyear=暂无数据, frequence=null, articleNumbers=1650, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1662-6575, greenSci=https://www.greensci.net/search?kw=1662-6575, scijournal=https://www.scijournal.org/impact-factor-of-CASE-REP-ONCOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=4.164, medsciHotlight=1.02, medsciHotlight5year=0.202, citescore=1.4, hIndex=19, impactFactor=0.8, orgnization=S. Karger AG, orgnizationUrl=https://www.karger.com/, country=Switzerland, countryCn=瑞典, isOa=1, isOaString=是, sciScie=null, bigclassCas=null, smallclassCas=, website=https://www.karger.com/Journal/Home/239061, websiteHits=321, guideForAuthor=https://www.karger.com/Journal/Guidelines/239061, guideForAuthorHits=213, submitWebsite=https://www.karger.com/Journal/Submission/239061, submitWebsiteHits=260, content=<h2 style="color: #333333;">Aims and Scope</h2> <p style="color: #333333;">Case Reports in Oncology is a peer-reviewed, open-access journal that publishes original case studies covering the entire spectrum of oncology, including prevention, diagnosis, treatment, toxicities of therapy, supportive care, quality-of-life, and survivorship issues. The journal will also accept case reports dealing with the use of novel technologies, both in the area of diagnosis and treatment. In this forum, clinicians and researchers can communicate their findings to a broader oncology community. The authors may also provide supplementary material free of charge.</p> <p style="color: #333333;"> </p> <h2 style="color: #333333;">Bibliographic Details</h2> <p style="color: #333333;"><strong>Case Reports in Oncology</strong><br />Journal Abbreviation: Case Rep Oncol<br />e-ISSN: 1662-6575 (Online)<br />DOI: 10.1159/issn.1662-6575</p> <h2 style="color: #333333;">Indexing/Abstracting</h2> <p style="color: #333333;">Listed in bibliographic services, including:<br /><br /><strong>PubMed </strong>| US National Library of Medicine<br /><strong>PubMed Central </strong>| US National Library of Medicine<br /><strong>Web of Science </strong>| Clarivate Analytics<br /><strong>Emerging Sources Citation Index </strong>| Clarivate Analytics<br /><strong>Google Scholar </strong>| Google<br /><strong>Chemical Abstracts Service </strong>| American Chemical Society<br /><strong>DOAJ: Directory of Open Access Journals</strong> <strong>Scopus </strong>| Elsevier<br /><strong>Embase </strong>| Elsevier<br /><strong>Pathway Studio </strong>| Elsevier<br /><strong>WorldCat </strong>| OCLC</p>, totalCites=1320, brief=CASE REP ONCOL杂志暂不明确行业，暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般，也很冷门，关注人少，审稿周期可能也不一定快，如果文章质量不佳，或时间不紧的话，可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='//www.sandwebs.com/sci/submit.do?id=6c7f21089'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2023, citescore=1.4)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=0.404), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=1.474), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=1.548), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=4.164)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1662-6575[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Case Reports in Oncology[ta], article_number=165, article_number_cn=6, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)